News

Press releases and news from regional sources, click on original post link to read the full article and see what’s trending. Click Here to Publish/Feature Your Company or Product News with Biotech Networks

No Picture
News

Calidi Biotherapeutics Announces Investor Event to be Held on Friday, November 7th at the 2025 SITC Annual Meeting

November 4, 2025 SDBN Comments Off on Calidi Biotherapeutics Announces Investor Event to be Held on Friday, November 7th at the 2025 SITC Annual Meeting

SAN DIEGO, Nov. 04, 2025 (GLOBE NEWSWIRE) — Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company pioneering the development of systemically delivered, targeted genetic medicines, today announced that it […]


ADVERTISEMENT — Advertise With Biotech Networks
News

BrainXell Therapeutics Unveils Promising Preclinical Data Demonstrating Efficacy of BXT-110, an Autologous iPSC-Derived Neuronal Therapy, in Parkinson’s Disease

November 3, 2025 SDBN Comments Off on BrainXell Therapeutics Unveils Promising Preclinical Data Demonstrating Efficacy of BXT-110, an Autologous iPSC-Derived Neuronal Therapy, in Parkinson’s Disease

SAN DIEGO, Nov. 3, 2025 /PRNewswire/ — BrainXell Therapeutics today announced the disclosure of its first scientific data, which will be presented at two conferences this month: the Cell Symposia | Gene and Cell-Based Therapies: […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Belite Bio to Host Webcast on November 10, 2025, to Discuss Third Quarter 2025 Financial Results

November 3, 2025 SDBN Comments Off on Belite Bio to Host Webcast on November 10, 2025, to Discuss Third Quarter 2025 Financial Results

SAN DIEGO, Nov. 03, 2025 (GLOBE NEWSWIRE) — Belite Bio, Inc (NASDAQ: BLTE), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced […]

No Picture
News

ARS Pharmaceuticals Announces Conference Call and Webcast for its Third Quarter 2025 Financial Results

November 3, 2025 SDBN Comments Off on ARS Pharmaceuticals Announces Conference Call and Webcast for its Third Quarter 2025 Financial Results

SAN DIEGO, Nov. 03, 2025 (GLOBE NEWSWIRE) — ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect patients from allergic reactions that could lead to […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Endeavor BioMedicines Receives Priority Medicines (PRIME) Designation from the European Medicines Agency for Taladegib (ENV-101) for the Treatment of Idiopathic Pulmonary Fibrosis

November 3, 2025 SDBN Comments Off on Endeavor BioMedicines Receives Priority Medicines (PRIME) Designation from the European Medicines Agency for Taladegib (ENV-101) for the Treatment of Idiopathic Pulmonary Fibrosis

SAN DIEGO–(BUSINESS WIRE)–Endeavor BioMedicines (“Endeavor”), a clinical-stage biotechnology company developing medicines with the potential to deliver transformational benefits to patients with life-threatening diseases, today announced that the European Medicines Agency (EMA) has granted PRIority MEdicines […]

News

QuidelOrtho Receives FDA 510(k) Clearance for VITROS™ Immunodiagnostic Products hs Troponin I Assay

November 3, 2025 SDBN Comments Off on QuidelOrtho Receives FDA 510(k) Clearance for VITROS™ Immunodiagnostic Products hs Troponin I Assay

Clearance expands menu and enables high-sensitivity troponin I measurement to aid in the diagnosis of myocardial infarction SAN DIEGO, Nov. 3, 2025 /PRNewswire/ — The U.S. Food and Drug Administration (“FDA”) has granted QuidelOrtho Corporation […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Belite Bio Announces UK’s Medicines and Healthcare Products Regulatory Agency Agrees to Conditional Marketing Authorization Application Based on Interim Analysis Results for the Treatment of Stargardt Disease with Tinlarebant

November 2, 2025 SDBN Comments Off on Belite Bio Announces UK’s Medicines and Healthcare Products Regulatory Agency Agrees to Conditional Marketing Authorization Application Based on Interim Analysis Results for the Treatment of Stargardt Disease with Tinlarebant

SAN DIEGO, Nov. 02, 2025 (GLOBE NEWSWIRE) — Belite Bio, Inc. (NASDAQ: BLTE), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced […]

News

Foresight Psychology, PLLC, Offers Testing for GRE, MCAT, GMAT, LSAT, and ACT, and SAT Exam Accommodations Nationwide.

October 31, 2025 SDBN Comments Off on Foresight Psychology, PLLC, Offers Testing for GRE, MCAT, GMAT, LSAT, and ACT, and SAT Exam Accommodations Nationwide.

Level the playing field and show your true potential SAN DIEGO, Oct. 31, 2025 /PRNewswire/ — Foresight Psychology is pleased to announce the availability of psychological testing services for individuals seeking accommodations on standardized exams. […]


ADVERTISEMENT — Advertise With Biotech Networks
News

Dr. Antoanella Calame Named “2025 Top Doctor”

October 30, 2025 SDBN Comments Off on Dr. Antoanella Calame Named “2025 Top Doctor”

SAN DIEGO, Oct. 30, 2025 /PRNewswire/ — Compass Dermatopathology proudly announces that its founder and director, Antoanella Calame, MD, a board-certified dermatologist and dermatopathologist, has been named one of San Diego’s 2025 “Top Doctors” in […]

No Picture
News

Avenzo Therapeutics to Present Initial Results from the Phase 1 Study of AVZO-021, a Potential Best-in-Class CDK2 Inhibitor, at the 2025 San Antonio Breast Cancer Symposium

October 30, 2025 SDBN Comments Off on Avenzo Therapeutics to Present Initial Results from the Phase 1 Study of AVZO-021, a Potential Best-in-Class CDK2 Inhibitor, at the 2025 San Antonio Breast Cancer Symposium

SAN DIEGO–(BUSINESS WIRE)–Avenzo to Present Initial Results from Phase 1 Study of AVZO-021, a Potential Best-in-Class CDK2 Inhibitor, at San Antonio Breast Cancer Symposium Click here to view original post Click Here to Publish/Feature Your […]

News

ChemDiv Extends CMC Services Collaboration for Ratutrelvir, a Potential Best-in-Class COVID-19 Therapeutic Advancing in Phase 2 Clinical Trials

October 30, 2025 SDBN Comments Off on ChemDiv Extends CMC Services Collaboration for Ratutrelvir, a Potential Best-in-Class COVID-19 Therapeutic Advancing in Phase 2 Clinical Trials

SAN DIEGO, Oct. 30, 2025 /PRNewswire/ — ChemDiv, a global provider of integrated drug discovery solutions, today announced the extension of its Chemistry, Manufacturing and Controls (CMC) services collaboration supporting the clinical development of ratutrelvir, […]


ADVERTISEMENT — Advertise With Biotech Networks
News

Researchers Uncover Previously Unexplored Details of Mosquito’s Specialized Detection Mechanisms

October 30, 2025 SDBN Comments Off on Researchers Uncover Previously Unexplored Details of Mosquito’s Specialized Detection Mechanisms

Researchers have captured unprecedented images of the mechanisms that allow mosquitoes, the world’s deadliest animal, to target our blood. The scientists used advanced imaging technology to assemble detailed visualizations of the neurons within hairs that […]

No Picture
News

Calidi Biotherapeutics Announces New Data to be Presented on its Therapeutic Lead, CLD-401, at the 2025 SITC Annual Meeting

October 30, 2025 SDBN Comments Off on Calidi Biotherapeutics Announces New Data to be Presented on its Therapeutic Lead, CLD-401, at the 2025 SITC Annual Meeting

SAN DIEGO, Oct. 30, 2025 (GLOBE NEWSWIRE) — Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company pioneering the development of systemically delivered, targeted genetic medicines, today announced the presentation […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Lineage Cell Therapeutics to Report Third Quarter 2025 Financial Results and Provide Business Update on November 6, 2025

October 30, 2025 SDBN Comments Off on Lineage Cell Therapeutics to Report Third Quarter 2025 Financial Results and Provide Business Update on November 6, 2025

CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #LineageCellTherapeutics–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic, or “off the shelf”, cell therapies for serious medical conditions, today announced that it will report […]

No Picture
News

SOTIO to Present Data Highlighting Progress Across ADC and Immunocytokine Programs at Upcoming Scientific Conferences

October 30, 2025 SDBN Comments Off on SOTIO to Present Data Highlighting Progress Across ADC and Immunocytokine Programs at Upcoming Scientific Conferences

PRAGUE & BASEL, Switzerland & BOSTON–(BUSINESS WIRE)–SOTIO Biotech, a clinical-stage biopharmaceutical company owned by PPF Group, today announced it will present new preclinical and translational data from multiple investigational programs at two scientific conferences in […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Prostate Cancer Foundation’s Scientific Retreat Showcases Latest Advancements From Renowned Leaders in Prostate Cancer Research

October 30, 2025 SDBN Comments Off on Prostate Cancer Foundation’s Scientific Retreat Showcases Latest Advancements From Renowned Leaders in Prostate Cancer Research

LOS ANGELES–(BUSINESS WIRE)–The Prostate Cancer Foundation (PCF) celebrated groundbreaking progress and innovation in the fight against prostate cancer at its 32nd Annual PCF Scientific Retreat, held October 23-25, 2025, in Carlsbad, California. The Scientific Retreat, […]

News

Bayview Recovery Center Offers Integrated Dual Diagnosis Treatment and Holistic Therapy for Men in San Diego

October 30, 2025 SDBN Comments Off on Bayview Recovery Center Offers Integrated Dual Diagnosis Treatment and Holistic Therapy for Men in San Diego

SAN DIEGO, Oct. 30, 2025 /PRNewswire/ — Bayview Recovery Center, a leading provider of outpatient addiction and mental health treatment in San Diego, CA, is advancing men’s behavioral health care through its integrated approach to […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

AltaSea Trustee Yehudi “Gaf” Gaffen to Receive Inaugural Gaffen Blue Champion Award at TMA BlueTech

October 29, 2025 SDBN Comments Off on AltaSea Trustee Yehudi “Gaf” Gaffen to Receive Inaugural Gaffen Blue Champion Award at TMA BlueTech

LOS ANGELES–(BUSINESS WIRE)–AltaSea at the Port of Los Angeles Trustee Yehudi “Gaf” Gaffen will be honored with the inaugural Gaffen Blue Champion Award for his visionary leadership in seeking to transform San Diego’s waterfront, driving […]